Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Times Interest Earned: 2014-2025

Historic Times Interest Earned for Ascendis Pharma A (ASND) over the last 12 years, with Sep 2025 value amounting to -$0.16.

  • Ascendis Pharma A's Times Interest Earned fell 104.31% to -$0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.24, marking a year-over-year increase of 4.33%. This contributed to the annual value of -$2.79 for FY2024, which is 73.04% up from last year.
  • According to the latest figures from Q3 2025, Ascendis Pharma A's Times Interest Earned is -$0.16, which was up 89.75% from -$1.60 recorded in Q2 2025.
  • In the past 5 years, Ascendis Pharma A's Times Interest Earned ranged from a high of $3.82 in Q3 2024 and a low of -$143.44 during Q1 2021.
  • Over the past 3 years, Ascendis Pharma A's median Times Interest Earned value was -$1.60 (recorded in 2025), while the average stood at -$3.95.
  • Its Times Interest Earned has fluctuated over the past 5 years, first crashed by 5,704.51% in 2021, then surged by 169.63% in 2024.
  • Ascendis Pharma A's Times Interest Earned (Quarterly) stood at -$84.58 in 2021, then surged by 93.06% to -$5.87 in 2022, then surged by 90.30% to -$0.57 in 2023, then surged by 101.13% to $0.01 in 2024, then tumbled by 104.31% to -$0.16 in 2025.
  • Its Times Interest Earned was -$0.16 in Q3 2025, compared to -$1.60 in Q2 2025 and -$2.33 in Q1 2025.